Welcome to our dedicated page for StandardAero news (Ticker: SARO), a resource for investors and traders seeking the latest updates and insights on StandardAero stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect StandardAero's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of StandardAero's position in the market.
StandardAero announced the pricing of its upsized initial public offering (IPO) of 60,000,000 shares of common stock at $24.00 per share. The offering includes 53,250,000 shares from StandardAero and 6,750,000 from existing stockholders. Trading is expected to begin on October 2, 2024, on the New York Stock Exchange under the symbol 'SARO'. The offering is set to close on October 3, 2024, subject to customary conditions.
The IPO size was increased from the previously announced 46,500,000 shares. Selling stockholders granted underwriters a 30-day option to purchase up to 9,000,000 additional shares. Lead book-running managers include J.P. Morgan, Morgan Stanley, BofA Securities, UBS Investment Bank, Jefferies, and RBC Capital Markets. The offering will be made only through a prospectus, with copies available from J.P. Morgan Securities and Morgan Stanley & Co.
FAQ
What is the current stock price of StandardAero (SARO)?